ZNTL Announces $1.2B Oncology Deal, $45M Cash, +30% Pipeline Growth, 2026 FDA Approval Target
Zentalis Pharmaceuticals, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $3.98
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS